You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Combination immunotherapies
452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rossi M, Belnoue E, Carboni S, et al
452 Combination treatment using KISIMATM protein-based cancer vaccine and systemic STING agonist results in profound modulation of tumor microenvironment and improved tumor control
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0452